Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program
Jardin F., Mareschal S., Figeac M., Jais J.P., Leroy K., Copie-Bergman C., Salles G.A., Coiffier B., Delarue R., Peyrade F. et al., 2012. pp. Abstract 415 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
ici le détail